EHWM
JNJ icon

Eads & Heald Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Eads & Heald Wealth Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Sell
9,754
-253
-3% -$58.9K 1.19% 26
2025
Q4 		$2.07M Sell
10,007
-171
-2% -$33.8K 1% 34
2025
Q3 		$1.89M Buy
10,178
+207
+2% +$35.5K 0.9% 46
2025
Q2 		$1.52M Sell
9,971
-36
-0.4% -$5.53K 0.75% 55
2025
Q1 		$1.66M Sell
10,007
-345
-3% -$54K 0.84% 54
2024
Q4 		$1.5M Sell
10,352
-17
-0.2% -$2.63K 0.74% 61
2024
Q3 		$1.68M Sell
10,369
-152
-1% -$24.2K 0.8% 54
2024
Q2 		$1.54M Sell
10,521
-369
-3% -$54.9K 0.74% 59
2024
Q1 		$1.72M Sell
10,890
-1,256
-10% -$200K 0.8% 57
2023
Q4 		$1.9M Sell
12,146
-100
-0.8% -$15.3K 0.92% 43
2023
Q3 		$1.91M Sell
12,246
-219
-2% -$36.1K 1% 41
2023
Q2 		$2.06M Sell
12,465
-521
-4% -$84.1K 1.01% 40
2023
Q1 		$2.01M Sell
12,986
-26
-0.2% -$4.2K 1% 39
2022
Q4 		$2.3M Buy
13,012
+432
+3% +$74.6K 1.17% 32
2022
Q3 		$2.06M Buy
12,580
+45
+0.4% +$7.62K 1.17% 30
2022
Q2 		$2.23M Sell
12,535
-170
-1% -$30.3K 1.2% 25
2022
Q1 		$2.25M Buy
12,705
+150
+1% +$25.5K 1.04% 39
2021
Q4 		$2.15M Sell
12,555
-2
-0% -$327 0.93% 50
2021
Q3 		$2.03M Buy
12,557
+26
+0.2% +$4.44K 0.98% 43
2021
Q2 		$2.06M Sell
12,531
-80
-0.6% -$13.2K 1.01% 43
2021
Q1 		$2.07M Buy
12,611
+35
+0.3% +$5.66K 1.06% 39
2020
Q4 		$1.98M Buy
12,576
+98
+0.8% +$14.5K 1.07% 38
2020
Q3 		$1.86M Sell
12,478
-1,436
-10% -$212K 1.11% 36
2020
Q2 		$1.96M Sell
13,914
-665
-5% -$96.9K 1.19% 32
2020
Q1 		$1.91M Sell
14,579
-518
-3% -$73.5K 1.35% 21
2019
Q4 		$2.2M Sell
15,097
-420
-3% -$57K 1.16% 31
2019
Q3 		$2.01M Sell
15,517
-195
-1% -$25.7K 1.12% 38
2019
Q2 		$2.19M Sell
15,712
-234
-1% -$32.4K 1.24% 26
2019
Q1 		$2.23M Buy
15,946
+438
+3% +$58.7K 1.29% 21
2018
Q4 		$2M Sell
15,508
-470
-3% -$65.6K 1.33% 22
2018
Q3 		$2.21M Buy
15,978
+265
+2% +$35.2K 1.27% 25
2018
Q2 		$1.91M Buy
15,713
+160
+1% +$20K 1.18% 33
2018
Q1 		$1.99M Sell
15,553
-563
-3% -$76.1K 1.26% 25
2017
Q4 		$2.25M Sell
16,116
-88
-0.5% -$12.3K 1.33% 14
2017
Q3 		$2.11M Sell
16,204
-215
-1% -$28.5K 1.31% 15
2017
Q2 		$2.17M Sell
16,419
-860
-5% -$110K 1.39% 12
2017
Q1 		$2.15M Sell
17,279
-249
-1% -$29.7K 1.39% 11
2016
Q4 		$2.02M Buy
17,528
+80
+0.5% +$9.24K 1.38% 10
2016
Q3 		$2.06M Sell
17,448
-209
-1% -$25.4K 1.42% 9
2016
Q2 		$2.14M Sell
17,657
-829
-4% -$94.2K 1.47% 6
2016
Q1 		$2M Sell
18,486
-705
-4% -$73K 1.38% 13
2015
Q4 		$1.97M Sell
19,191
-175
-0.9% -$17.6K 1.36% 19
2015
Q3 		$1.81M Sell
19,366
-10
-0.1% -$967 1.29% 20
2015
Q2 		$1.89M Sell
19,376
-156
-0.8% -$15.6K 1.24% 26
2015
Q1 		$1.97M Sell
19,532
-425
-2% -$43.2K 1.26% 25
2014
Q4 		$2.09M Sell
19,957
-175
-0.9% -$18.4K 1.33% 24
2014
Q3 		$2.15M Sell
20,132
-1,277
-6% -$132K 1.45% 7
2014
Q2 		$2.24M Sell
21,409
-1,691
-7% -$171K 1.49% 3
2014
Q1 		$2.27M Sell
23,100
-406
-2% -$37.6K 1.49% 10
2013
Q4 		$2.15M Sell
23,506
-464
-2% -$42.8K 1.43% 17
2013
Q3 		$2.08M Sell
23,970
-1,618
-6% -$145K 1.48% 7
2013
Q2 		$2.2M Buy
+25,588
New +$2.17M 1.56% 5

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eads & Heald Wealth Management's JNJ Position: Q1 2026 in Review

Eads & Heald Wealth Management reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, selling an estimated $58.9K and leaving 9,754 shares worth $2.38M. The position accounts for 1.19% of the portfolio, ranked #26.

Eads & Heald Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Eads & Heald Wealth Management held 9,754 shares of Johnson & Johnson worth $2.38M as of Q1 2026.
  • Eads & Heald Wealth Management sold 253 Johnson & Johnson shares in Q1 2026, an estimated $58.9K.
  • Johnson & Johnson made up 1.19% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #26 holding.
  • Eads & Heald Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.